A multicultural group practicing yoga together in a bright studio

Sprout Health vs Willow: GLP-1 Comparison 2026

Sprout Health vs Willow: pricing, medication type, clinical support, and which mid-market GLP-1 patient each program fits. Both programs’ prices verified August 2026 or later; each price carries its own date in the table below.

By RangeYourselfUpdated September 15, 20264 min read

Quick answer

Sprout Health and Willow both offer GLP-1 telehealth, but they package medication, support, and pricing differently. The right choice depends on whether you weight cost, clinical touch, or formulation flexibility highest.

Side-by-side comparison

Feature	Sprout Health	Willow
Best for	Balance of price and clinical support	Compounded GLP-1 shoppers who want a choice between injectable and needle-free sublingual tablets for both semaglutide and tirzepatide, in one of Willow's 36 served states
Medication type	Compounded semaglutide and tirzepatide; brand-name Wegovy/Zepbound listed cash-pay	Compounded GLP-1 (semaglutide) and GLP-1/GIP (tirzepatide), your choice of once-weekly injection or once-daily sublingual tablet; NAD+ also offered
Pricing model	Public 'starting at' monthly pricing on the homepage; higher doses/formats confirmed in the signup funnel	Cash-pay subscription; semaglutide (injection or tablet) from $299/mo, tirzepatide (injection or tablet) from $399/mo. Willow's own FAQ states medication cost "varies by dosage and prescription," so these are starting prices, not flat rates.
Semaglutide price	From $149/mo, advertised 'starting at' (compounded semaglutide, entry dose; homepage-verified 2026-08-21); personalized rate confirmed in the signup funnel	Compounded, from $299/mo, your choice of once-weekly injection or once-daily sublingual tablet (verified 2026-09-15). Willow's own FAQ notes cost varies by dosage and prescription, confirm your exact rate in the assessment.
Tirzepatide price	From $199/mo, advertised 'starting at' (compounded tirzepatide, entry dose; homepage-verified 2026-08-21); personalized rate confirmed in the signup funnel	Compounded GLP-1/GIP, from $399/mo, your choice of once-weekly injection or once-daily sublingual tablet (verified 2026-09-15). Same dosage-based pricing applies, confirm your exact rate in the assessment.
Key watchout	The $149 (semaglutide) / $199 (tirzepatide) figures are Sprout's advertised homepage 'starting at' entry-dose prices, verified on the homepage 2026-07-16. The signup funnel personalizes the final rate; higher doses and brand-name options (Wegovy ~$1,799/mo, Zepbound ~$1,999/mo) cost more, confirm your dose's rate at enrollment	Willow lists $299/mo (semaglutide) and $399/mo (tirzepatide) as starting prices; its own FAQ states medication cost "varies by dosage and prescription," so confirm your exact recurring rate during the assessment. Willow is available in 36 states, not all 50.
Price checked	Checked by a person August 21, 2026 · an automated check re-read it September 21, 2026	Checked by a person September 15, 2026 · an automated check re-read it September 21, 2026

When to choose Sprout Health

You want one of the lowest bundled compounded entry prices with clinician access
You're looking for compounded GLP-1 without a stripped-down service tier
You're comfortable confirming the recurring price in the signup funnel before committing
You may want to escalate dose with the same provider over time

Check current Sprout Health pricing →

When to choose Willow

You want a choice between injectable and needle-free sublingual tablets for both semaglutide and tirzepatide
You live in one of the 36 states Willow currently serves
You want FSA/HSA-eligible billing with no separate membership fee
You're comfortable confirming your exact recurring rate in the assessment, since Willow's own FAQ says price varies by dosage

Check current Willow pricing →

Full reviews

Frequently asked questions

Is Sprout Health cheaper than Willow?

Sprout Health starts lower on semaglutide (From $149/mo, advertised 'starting at' (compounded semaglutide, entry dose; homepage-verified 2026-08-21); personalized rate confirmed in the signup funnel). Sprout Health starts lower on tirzepatide (From $199/mo, advertised 'starting at' (compounded tirzepatide, entry dose; homepage-verified 2026-08-21); personalized rate confirmed in the signup funnel). Higher doses can shift the picture, so confirm pricing at the dose you're likely to use long-term.

Which is better for semaglutide or tirzepatide, Sprout Health or Willow?

Sprout Health starts lower on both semaglutide and tirzepatide based on listed entry pricing. That said, the right pick is the program whose support model and formulation match what you actually need.

Are Sprout Health and Willow compounded or brand-name?

Sprout Health offers compounded semaglutide and tirzepatide; brand-name wegovy/zepbound listed cash-pay. Willow offers compounded glp-1 (semaglutide) and glp-1/gip (tirzepatide), your choice of once-weekly injection or once-daily sublingual tablet; nad+ also offered. If you specifically want brand-name Wegovy or Zepbound, lean toward whichever explicitly supports brand access; if compounded is fine, both can typically meet that need.

Can I switch from Sprout Health to Willow?

Yes, switching between Sprout Health and Willow is straightforward in most states. You typically finish your current month, complete a new intake with the other provider, and they handle the prescription. Watch for overlap on auto-renewal billing and confirm any dose-tier or formulation differences with the new clinician before your next shipment.

Compare Sprout Health and Willow to other programs

Alert me when this gets cheaper

These prices move. Get one email when we publish a verified price drop, the programs on this list included. No spam. Unsubscribe any time.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers, verified on the dates shown in the table above, and may change. Numbers like $149/mo, advertised 'starting at' (compounded semaglutide, entry dose; homepage-verified 2026-08-21); personalized rate confirmed in the signup funnel and Compounded, from $299/mo, your choice of once-weekly injection or once-daily sublingual tablet (verified 2026-09-15). Willow's own FAQ notes cost varies by dosage and prescription, confirm your exact rate in the assessment. are starting tiers, not your guaranteed long-term cost.